CURIS, INC. Deferred Tax Assets, Tax Deferred Expense
CURIS, INC. (CRIS) had Deferred Tax Assets, Tax Deferred Expense of $112.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsTaxDeferredExpense · last filed 2026-03-24
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense $112.00K.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense $154.00K.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense $973.00K.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense $1.07M.
| Period end | Deferred Tax Assets, Tax Deferred Expense |
|---|---|
| 2025-12-31 | $112.00K 10-K · filed 2026-03-24 |
| 2024-12-31 | $154.00K 10-K · filed 2026-03-24 |
| 2023-12-31 | $973.00K 10-K · filed 2025-03-31 |
| 2022-12-31 | $1.07M 10-K · filed 2024-02-08 |
| 2021-12-31 | $916.00K 10-K · filed 2023-03-13 |
| 2020-12-31 | $708.00K 10-K · filed 2022-02-24 |
| 2019-12-31 | $131.00K 10-K · filed 2021-03-16 |
| 2018-12-31 | $259.00K 10-K · filed 2020-03-19 |
| 2017-12-31 | $155.00K 10-K · filed 2019-03-26 |
| 2016-12-31 | $176.00K 10-K · filed 2018-03-08 |
| 2015-12-31 | $113.00K 10-K · filed 2017-03-09 |
| 2014-12-31 | $114.00K 10-K · filed 2016-02-29 |
| 2013-12-31 | $118.00K 10-K · filed 2015-02-24 |
| 2012-12-31 | $707.00K 10-K · filed 2014-03-13 |
| 2011-12-31 | $1.82M 10-K · filed 2013-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |